{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Vasco Da Gama",
      "state": "",
      "country": "India",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "81795",
      "recalling_firm": "Cipla Limited",
      "address_1": "L129 - 146 S - 103 - 105 S - 107 - 112 L147 - L147/1/2/3 L147/A",
      "address_2": "",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within the United States",
      "recall_number": "D-0382-2019",
      "product_description": "Nevirapine Extended Release Tablets, 400 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd. Verna Goa, India, Manufactured for: Cipla USA Inc. 9100 S Dadeland Blvd., Suite 1500 Miami, FL 33156, NDC 69097-403-02",
      "product_quantity": "4800 bottles",
      "reason_for_recall": "Failed Dissolution Specifications.",
      "recall_initiation_date": "20181214",
      "center_classification_date": "20190116",
      "termination_date": "20200708",
      "report_date": "20181226",
      "code_info": "Lot #:  GG80257, Exp. 12/2019",
      "more_code_info": ""
    }
  ]
}